Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Brian G. Atwood currently holds 1,612,099 shares of Trius Therapeutics Inc (TSRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brian G. Atwood has been a net buyer of TSRX stock. They have purchased $15.5M and sold $2.5M worth of shares.
Brian G. Atwood's most recent insider trade was on Jan 7, 2026, when they sold 1,612,099 shares at $0.00 per share.
Brian G. Atwood serves as Executive at Trius Therapeutics Inc (TSRX). They have executed 101 insider transactions totaling $18.0M over their tenure at the company.
Brian G. Atwood holds the position of Executive at Trius Therapeutics Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Brian G. Atwood has shown a buying trading pattern, with $15.5M in total purchases and $2.5M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Brian G. Atwood was on May 23, 2016, when they purchased $3.0M worth of PZRX shares. This transaction involved 596,477 shares at $5.00 per share.
Brian G. Atwood currently owns 1,612,099 shares of Trius Therapeutics Inc (TSRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Brian G. Atwood's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Brian G. Atwood has 101 Form 4 filings on record as an insider at Trius Therapeutics Inc.
Set alerts for Brian G. Atwood and 40,000+ other insiders.